Selected research
Industry Growth & Trends
Global Omega3 (Omega-3) Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Omega3 (Omega-3) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Omega3 (Omega-3) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Omega3 (Omega-3) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Omega3 (Omega-3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Omega3 (Omega-3) market include DSM, Skuny, Shandong Yuwang Pharmaceutical, BASF, Xinzhou, TASA, Solutex, Sinomega and Polaris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Omega3 (Omega-3) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Omega3 (Omega-3) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Omega3 (Omega-3) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Omega3 (Omega-3).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Omega3 (Omega-3) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Omega3 (Omega-3) Market by Company
DSM
Skuny
Shandong Yuwang Pharmaceutical
BASF
Xinzhou
TASA
Solutex
Sinomega
Polaris
Orkla Health
Omega Protein
OLVEA Fish Oils
Nippon Suisan Kaisha
Maruha Nichiro Foods
LYSI
Kinomega
KD Pharma(Marine Ingredients)
KD Pharma
Hofseth BioCare
Golden Omega
GC Rieber
EPAX
Croda
Bioprocess Algae
Auqi
Anti-Cancer
Omega3 (Omega-3) Segment by Type
Marine Source
Algae Source
Omega3 (Omega-3) Segment by Application
Pharmaceuticals
Infant Formula
Dietary Supplements
Fortified Food and Beverage
Pet Foods
Others
Omega3 (Omega-3) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega3 (Omega-3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omega3 (Omega-3) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega3 (Omega-3).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Omega3 (Omega-3) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Source
- Algae Source
Applications
- Pharmaceuticals
- Infant Formula
- Dietary Supplements
- Fortified Food and Beverage
- Pet Foods
- Others
Companies covered
- DSM
- Skuny
- Shandong Yuwang Pharmaceutical
- BASF
- Xinzhou
- TASA
- Solutex
- Sinomega
- Polaris
- Orkla Health
- Omega Protein
- OLVEA Fish Oils
- Nippon Suisan Kaisha
- Maruha Nichiro Foods
- LYSI
- Kinomega
- KD Pharma(Marine Ingredients)
- KD Pharma
- Hofseth BioCare
- Golden Omega
- GC Rieber
- EPAX
- Croda
- Bioprocess Algae
- Auqi
- Anti-Cancer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Omega3 (Omega-3) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Omega3 (Omega-3) Market Size by Region (2021-2032)
- 1.4.1 Global Omega3 (Omega-3) Market Size by Region (2021-2026)
- 1.4.2 Global Omega3 (Omega-3) Market Size by Region (2027-2032)
- 1.5 Key Regions Omega3 (Omega-3) Market Size (2021-2032)
- 1.5.1 North America Omega3 (Omega-3) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Omega3 (Omega-3) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Omega3 (Omega-3) Market Size Growth Rate (2021-2032)
- 1.5.4 South America Omega3 (Omega-3) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Omega3 (Omega-3) Market Size Growth Rate (2021-2032)
2 Omega3 (Omega-3) Market by Type
- 2.1 Type Introduction
- 2.1.1 Marine Source
- 2.1.2 Algae Source
- 2.2 Global Omega3 (Omega-3) Market Size by Type
- 2.2.1 Global Omega3 (Omega-3) Market Size Overview by Type (2021-2032)
- 2.2.2 Global Omega3 (Omega-3) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Omega3 (Omega-3) Market Size Forecasted by Type (2027-2032)
- 2.3 Global Omega3 (Omega-3) Market Size by Regions
- 2.3.1 North America Omega3 (Omega-3) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Omega3 (Omega-3) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Omega3 (Omega-3) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Omega3 (Omega-3) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Omega3 (Omega-3) Market Size Breakdown by Type (2021-2026)
3 Omega3 (Omega-3) Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceuticals
- 3.1.2 Infant Formula
- 3.1.3 Dietary Supplements
- 3.1.4 Fortified Food and Beverage
- 3.1.5 Pet Foods
- 3.1.6 Others
- 3.2 Global Omega3 (Omega-3) Market Size by Application
- 3.2.1 Global Omega3 (Omega-3) Market Size Overview by Application (2021-2032)
- 3.2.2 Global Omega3 (Omega-3) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Omega3 (Omega-3) Market Size Forecasted by Application (2027-2032)
- 3.3 Global Omega3 (Omega-3) Market Size by Regions
- 3.3.1 North America Omega3 (Omega-3) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Omega3 (Omega-3) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Omega3 (Omega-3) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Omega3 (Omega-3) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Omega3 (Omega-3) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Omega3 (Omega-3) Industry Trends
- 4.2 Omega3 (Omega-3) Industry Drivers
- 4.3 Omega3 (Omega-3) Industry Opportunities and Challenges
- 4.4 Omega3 (Omega-3) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Omega3 (Omega-3) Revenue (2021-2026)
- 5.2 Global Omega3 (Omega-3) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Omega3 (Omega-3) Key Company Headquarters & Area Served
- 5.4 Global Omega3 (Omega-3) Company, Product Type & Application
- 5.5 Global Omega3 (Omega-3) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Omega3 (Omega-3) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Omega3 (Omega-3) Players Market Share by Revenue in 2025
- 5.6.3 2025 Omega3 (Omega-3) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 DSM
- 6.1.1 DSM Company Information
- 6.1.2 DSM Business Overview
- 6.1.3 DSM Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 DSM Omega3 (Omega-3) Product Portfolio
- 6.1.5 DSM Recent Developments
- 6.2 Skuny
- 6.2.1 Skuny Company Information
- 6.2.2 Skuny Business Overview
- 6.2.3 Skuny Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Skuny Omega3 (Omega-3) Product Portfolio
- 6.2.5 Skuny Recent Developments
- 6.3 Shandong Yuwang Pharmaceutical
- 6.3.1 Shandong Yuwang Pharmaceutical Company Information
- 6.3.2 Shandong Yuwang Pharmaceutical Business Overview
- 6.3.3 Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Product Portfolio
- 6.3.5 Shandong Yuwang Pharmaceutical Recent Developments
- 6.4 BASF
- 6.4.1 BASF Company Information
- 6.4.2 BASF Business Overview
- 6.4.3 BASF Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 BASF Omega3 (Omega-3) Product Portfolio
- 6.4.5 BASF Recent Developments
- 6.5 Xinzhou
- 6.5.1 Xinzhou Company Information
- 6.5.2 Xinzhou Business Overview
- 6.5.3 Xinzhou Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Xinzhou Omega3 (Omega-3) Product Portfolio
- 6.5.5 Xinzhou Recent Developments
- 6.6 TASA
- 6.6.1 TASA Company Information
- 6.6.2 TASA Business Overview
- 6.6.3 TASA Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 TASA Omega3 (Omega-3) Product Portfolio
- 6.6.5 TASA Recent Developments
- 6.7 Solutex
- 6.7.1 Solutex Company Information
- 6.7.2 Solutex Business Overview
- 6.7.3 Solutex Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Solutex Omega3 (Omega-3) Product Portfolio
- 6.7.5 Solutex Recent Developments
- 6.8 Sinomega
- 6.8.1 Sinomega Company Information
- 6.8.2 Sinomega Business Overview
- 6.8.3 Sinomega Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sinomega Omega3 (Omega-3) Product Portfolio
- 6.8.5 Sinomega Recent Developments
- 6.9 Polaris
- 6.9.1 Polaris Company Information
- 6.9.2 Polaris Business Overview
- 6.9.3 Polaris Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Polaris Omega3 (Omega-3) Product Portfolio
- 6.9.5 Polaris Recent Developments
- 6.10 Orkla Health
- 6.10.1 Orkla Health Company Information
- 6.10.2 Orkla Health Business Overview
- 6.10.3 Orkla Health Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Orkla Health Omega3 (Omega-3) Product Portfolio
- 6.10.5 Orkla Health Recent Developments
- 6.11 Omega Protein
- 6.11.1 Omega Protein Company Information
- 6.11.2 Omega Protein Business Overview
- 6.11.3 Omega Protein Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Omega Protein Omega3 (Omega-3) Product Portfolio
- 6.11.5 Omega Protein Recent Developments
- 6.12 OLVEA Fish Oils
- 6.12.1 OLVEA Fish Oils Company Information
- 6.12.2 OLVEA Fish Oils Business Overview
- 6.12.3 OLVEA Fish Oils Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 OLVEA Fish Oils Omega3 (Omega-3) Product Portfolio
- 6.12.5 OLVEA Fish Oils Recent Developments
- 6.13 Nippon Suisan Kaisha
- 6.13.1 Nippon Suisan Kaisha Company Information
- 6.13.2 Nippon Suisan Kaisha Business Overview
- 6.13.3 Nippon Suisan Kaisha Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Nippon Suisan Kaisha Omega3 (Omega-3) Product Portfolio
- 6.13.5 Nippon Suisan Kaisha Recent Developments
- 6.14 Maruha Nichiro Foods
- 6.14.1 Maruha Nichiro Foods Company Information
- 6.14.2 Maruha Nichiro Foods Business Overview
- 6.14.3 Maruha Nichiro Foods Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Maruha Nichiro Foods Omega3 (Omega-3) Product Portfolio
- 6.14.5 Maruha Nichiro Foods Recent Developments
- 6.15 LYSI
- 6.15.1 LYSI Company Information
- 6.15.2 LYSI Business Overview
- 6.15.3 LYSI Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 LYSI Omega3 (Omega-3) Product Portfolio
- 6.15.5 LYSI Recent Developments
- 6.16 Kinomega
- 6.16.1 Kinomega Company Information
- 6.16.2 Kinomega Business Overview
- 6.16.3 Kinomega Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Kinomega Omega3 (Omega-3) Product Portfolio
- 6.16.5 Kinomega Recent Developments
- 6.17 KD Pharma(Marine Ingredients)
- 6.17.1 KD Pharma(Marine Ingredients) Company Information
- 6.17.2 KD Pharma(Marine Ingredients) Business Overview
- 6.17.3 KD Pharma(Marine Ingredients) Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 KD Pharma(Marine Ingredients) Omega3 (Omega-3) Product Portfolio
- 6.17.5 KD Pharma(Marine Ingredients) Recent Developments
- 6.18 KD Pharma
- 6.18.1 KD Pharma Company Information
- 6.18.2 KD Pharma Business Overview
- 6.18.3 KD Pharma Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 KD Pharma Omega3 (Omega-3) Product Portfolio
- 6.18.5 KD Pharma Recent Developments
- 6.19 Hofseth BioCare
- 6.19.1 Hofseth BioCare Company Information
- 6.19.2 Hofseth BioCare Business Overview
- 6.19.3 Hofseth BioCare Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Hofseth BioCare Omega3 (Omega-3) Product Portfolio
- 6.19.5 Hofseth BioCare Recent Developments
- 6.20 Golden Omega
- 6.20.1 Golden Omega Company Information
- 6.20.2 Golden Omega Business Overview
- 6.20.3 Golden Omega Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Golden Omega Omega3 (Omega-3) Product Portfolio
- 6.20.5 Golden Omega Recent Developments
- 6.21 GC Rieber
- 6.21.1 GC Rieber Company Information
- 6.21.2 GC Rieber Business Overview
- 6.21.3 GC Rieber Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 GC Rieber Omega3 (Omega-3) Product Portfolio
- 6.21.5 GC Rieber Recent Developments
- 6.22 EPAX
- 6.22.1 EPAX Company Information
- 6.22.2 EPAX Business Overview
- 6.22.3 EPAX Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 EPAX Omega3 (Omega-3) Product Portfolio
- 6.22.5 EPAX Recent Developments
- 6.23 Croda
- 6.23.1 Croda Company Information
- 6.23.2 Croda Business Overview
- 6.23.3 Croda Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Croda Omega3 (Omega-3) Product Portfolio
- 6.23.5 Croda Recent Developments
- 6.24 Bioprocess Algae
- 6.24.1 Bioprocess Algae Company Information
- 6.24.2 Bioprocess Algae Business Overview
- 6.24.3 Bioprocess Algae Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Bioprocess Algae Omega3 (Omega-3) Product Portfolio
- 6.24.5 Bioprocess Algae Recent Developments
- 6.25 Auqi
- 6.25.1 Auqi Company Information
- 6.25.2 Auqi Business Overview
- 6.25.3 Auqi Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Auqi Omega3 (Omega-3) Product Portfolio
- 6.25.5 Auqi Recent Developments
- 6.26 Anti-Cancer
- 6.26.1 Anti-Cancer Company Information
- 6.26.2 Anti-Cancer Business Overview
- 6.26.3 Anti-Cancer Omega3 (Omega-3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 Anti-Cancer Omega3 (Omega-3) Product Portfolio
- 6.26.5 Anti-Cancer Recent Developments
7 North America
- 7.1 North America Omega3 (Omega-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Omega3 (Omega-3) Market Size by Country (2021-2026)
- 7.3 North America Omega3 (Omega-3) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Omega3 (Omega-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Omega3 (Omega-3) Market Size by Country (2021-2026)
- 8.3 Europe Omega3 (Omega-3) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Omega3 (Omega-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Omega3 (Omega-3) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Omega3 (Omega-3) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Omega3 (Omega-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Omega3 (Omega-3) Market Size by Country (2021-2026)
- 10.3 South America Omega3 (Omega-3) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Omega3 (Omega-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Omega3 (Omega-3) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Omega3 (Omega-3) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst